ASCO: Survival Benefit With Docetaxel in High-Risk Prostate Cancer
(MedPage Today) -- For the first time, adjuvant chemotherapy improves survival in the localized setting
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Geriatrics | Prostate Cancer | Taxotere